Development and validation of the Decisional Balance Scale for problematic Prescription Drug use (DBS-PD)-20

Sabine I. Braun*, Gallus Bischof, Hans Jürgen Rumpf

*Korrespondierende/r Autor/-in für diese Arbeit
    1 Zitat (Scopus)

    Abstract

    The purpose of this study was to develop a Decisional Balance Scale (DBS) for Prescription Drugs (PD), the DBS-PD-20, to examine its factorial structure and test its reliability and external validity by comparison across Stages of Change. A sample of 126 general hospital inpatients with either regular use of PD (more than 60. days within the last three months) or abuse of or dependence on PD was recruited in a northern German city. Exploratory principal components analysis revealed a two-factor structure, the Pros and Cons of PD intake, as expected. While the DBS-PD-20 showed good reliability (Cronbach's alpha = 0.91 for the Pros and = 0.89 for the Cons), external validity could be proven for the Cons (significant increase from precontemplation to contemplation/action), whereas the Pros showed an insignificant increase. Although further validation is needed, the DBS-PD-20 may be helpful for interventions and research.

    OriginalspracheEnglisch
    ZeitschriftAddictive behaviors
    Jahrgang37
    Ausgabenummer4
    Seiten (von - bis)444-448
    Seitenumfang5
    ISSN0306-4603
    DOIs
    PublikationsstatusVeröffentlicht - 04.2012

    Strategische Forschungsbereiche und Zentren

    • Forschungsschwerpunkt: Gehirn, Hormone, Verhalten - Center for Brain, Behavior and Metabolism (CBBM)

    Fingerprint

    Untersuchen Sie die Forschungsthemen von „Development and validation of the Decisional Balance Scale for problematic Prescription Drug use (DBS-PD)-20“. Zusammen bilden sie einen einzigartigen Fingerprint.

    Zitieren